Name: UMIN ID:
Unique ID issued by UMIN | C000000065 |
---|---|
Receipt number | R000000106 |
Scientific Title | Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202) |
Date of disclosure of the study information | 2005/08/17 |
Last modified on | 2008/12/17 23:07:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/08/17 18:27:19 | ||
2 | Update | 2005/08/17 20:03:30 | Public title Public title Acronym Acronym |
|
3 | Update | 2006/03/14 12:22:52 | URL related to results and publications Results Results |
|
4 | Update | 2006/03/30 16:46:35 | URL related to results and publications |
|
5 | Update | 2007/06/22 00:00:48 | Publication of results Results Results |
|
6 | Update | 2008/07/04 01:02:56 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2008/12/17 23:07:45 | Division name Division name Last name of contact person Last name of contact person Division name Division name TEL Name of person sending information Name of person sending information Division name Division name TEL |